Unlearn.AI Company

Unlearn.AI is a developer of a platform designed to make computational clinical trials. The company's platform accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, that helps in reducing the time to develop new medicines, enabling healthcare companies to sooner provide patients in need with life-saving therapies.
Technology: AI
Industry: Artificial Intelligence, Bioinformatics, Biopharma, Clinical Trials, Computer, Life Science, Machine Learning, Software
Headquarters: San Francisco, California, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: $12M
Estimated Revenue: $1M to $10M
Last Funding Type: Series A

Visit Website
info@unlearn.ai
https://twitter.com/unlearnai
Register and Claim Ownership